P567: CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA – INCIDENCE AND OUTCOME

Autor: M. Virijevic, I. Djunic, M. Mitrovic, N. Pantic, Z. Pravdic, N. Sabljic, A. Novkovic, M. Cvetovic, J. Rajic, A. Vidovic, M. Todorovic-Balint, N. Suvajdzic-Vukovic

Publikováno v: HemaSphere, Vol 6, Pp 466-467 (2022)

Externí odkaz: https://doaj.org/article/83ca7fa1df1e403f8aa178f713e03a08

PB1832: ARTERIAL THROMBOSIS AND ACUTE MYELOID LEUKEMIA – IS THERE A CONNECTION?

Autor: N. Pantic, M. Virijevic, Z. Pravdic, N. Sabljic, Z. Bukumiric, M. Cvetkovic, J. Rajic, A. Vidovic, M. Todorovic-Balint, N. Suvajdzic-Vukovic, D. Antic, M. Mitrovic

Publikováno v: HemaSphere, Vol 6, Pp 1712-1713 (2022)

Externí odkaz: https://doaj.org/article/808ef780e1ce492699446c7da3775b55

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Contemporary Distribution of High-Grade Prostate Cancer in the Circumstances of Opportunistic Testing

Autor: Milorad Stojadinovic, Damjan N Pantic, Miroslav M. Stojadinović

Publikováno v: Serbian Journal of Experimental and Clinical Research, Vol 21, Iss 4, Pp 299-305 (2020)
Serbian Journal of Experimental and Clinical Research (2020) 21(4):299-305

Screening has dramatically changed the distribution of the mean age, stage and grade of prostate cancer (PCa) at diagnosis. However, regional-level data that characterize contemporary PCa patients are limited. The aim of the study was to ascertain ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0154b8cd02512c634486e3c232d724d
https://doaj.org/article/4d5108f863d045ddaa7e9925311dfbc8

Decision tree analysis for prostate cancer prediction in patients with serum PSA 10 ng/ml or less

Autor: Milorad Stojadinovic, Damjan N Pantic, Miroslav M. Stojadinović

Publikováno v: Serbian Journal of Experimental and Clinical Research (2020) 21(1):43-50
Serbian Journal of Experimental and Clinical Research, Vol 21, Iss 1, Pp 43-50 (2020)

Serum prostate-specific antigen (PSA) testing increases the number of persons who undergo prostate biopsy. However, the best possible strategy for selecting patients for prostate biopsy has not yet been defined. The aim of this study was to develop a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9947065e4d200aaf1549a462cc9a24d1
http://scindeks.ceon.rs/article.aspx?artid=1820-86652001043P